Toronto, Ontario, M5V 2T3, Canada
NCT Number: NCT00429468
A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers
The purpose of this research study is to determine if varying strengths of ethanol affect the drug level and safety profile of Vicodin® CR.
Looking for future studies?
Notify MeKey information
Conditions
Age range
19 year–55 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 1
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Males and females ages 19 to 55
- If female, must be of non-child bearing potential or practicing birth control
- Current alcohol users who are classified as moderate drinkers (defined as 7-21 drinks per week)
Exclusion criteria
- Intolerance towards ethanol
- Is allergic to or has a serious reaction to hydrocodone, other opioids, or acetaminophen
- Significant GI narrowing or abnormality with a potential to inhibit GI motility or tablet transport
- History of seizures or convulsions, head injury or other intracranial lesions, or a pre-existing increase in intracranial pressure
- Has any clinically significant abnormalities on physical examination, ECG, or laboratory values
- Treatment with any investigational drug within 30 days of administration of study drug in the Treatment Phase
Treatment and study plan
Vicodin® CR (extended-release hydrocodone/acetaminophen)
DrugPrimary outcomes
-
Standard pharmacokinetic assessments
-
statistical, clinical and laboratory procedures
Sponsors and collaborators
Lead sponsor
Abbott
Industry
Registry information
Official study title
A Single-Centre, Double-Blind, Randomized, Placebo-Controlled, Phase 1 Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers
Important dates
- Study start
- 2007
- First posted
- Jan 31, 2007
- Registry last updated
- Oct 26, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
KF2024#1-trial: Esketamine Interaction Study
NCT06726382
Drug Interactions, Food-drug Interaction
Helsinki, Finland
View Trial DetailsStudy to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib
NCT06717100
Drug Interactions, Fibrosis
Melbourne, Victoria, Australia
View Trial DetailsDrug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects
NCT05657613
Drug Interactions
Austin, Texas, United States
View Trial DetailsInteraction of Sevoflurane Propofol and Remifentanil in Anesthesia for Laparoscopic Surgery
NCT02457442
Anesthesia, Conduction, Drug Interactions
Bern, Switzerland
View Trial Details